Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

PHASE4UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Non-small-cell Lung Cancer
Interventions
DRUG

Icotinib plus WBRT

Standard whole brain radiotherapy is given with 4000cGY/20 times, plus icotinib, which was administered orally three times per day.

Trial Locations (1)

Unknown

RECRUITING

Baotou Central Hospital, Baotou

All Listed Sponsors
lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY

NCT01926171 - Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases | Biotech Hunter | Biotech Hunter